Search research articles
Contact Us
Filters
Showing results (291-300 of 688) with videos related to
Page
of 69
Sort By:
Antioxidants (Basel, Switzerland)
|
December 23, 2022
Characterization of Bioactive Compounds in Lees from New Zealand Wines with Different Vinification Backgrounds
Zhijing Ye, Yunxuan Qin, Roland Harrison, et al.
International Journal of Molecular Sciences
|
January 12, 2017
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
Ruslan Cusnir, Cinzia Imberti, Robert C Hider, et al.
Dalton Transactions (Cambridge, England : 2003)
|
February 18, 2015
Deferitazole, a new orally active iron chelator
Robert C Hider, Xiaole Kong, Vincenzo Abbate, et al.
The British Journal of Surgery
|
July 6, 2010
Computed tomographic colonography in the diagnosis of colorectal cancer
M Sabanli, A Balasingam, W Bailey, et al.
Journal of Medicinal Chemistry
|
April 1, 2017
Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy
Sinan Battah, Robert C Hider, Alexander J MacRobert, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 1, 1995
Tryptic mapping of human chorionic gonadotropin by matrix-assisted laser desorption/ionization mass spectrometry
P Laidler, D A Cowan, R C Hider, et al.
British Journal of Haematology
|
June 6, 2003
Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry
Roland Fischer, Filomena Longo, Peter Nielsen, et al.
Journal of Medicinal Chemistry
|
February 21, 2012
Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake
Yongmin Ma, Sourav Roy, Xiaole Kong, et al.
Journal of Health Politics, Policy and Law
|
December 6, 2002
Compensation for medical injury in New Zealand: does "'no-fault" increase the level of claims making and reduce social and clinical selectivity?
Peter Davis, Roy Lay-Yee, Julie Fitzjohn, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
S L Hider, A Silman, D Bunn, et al.
Page
of 69
Search research articles
Search
Showing results (291-300 of 688) with videos related to
Sort By:
Page
of 69
Antioxidants (Basel, Switzerland)
|
December 23, 2022
Characterization of Bioactive Compounds in Lees from New Zealand Wines with Different Vinification Backgrounds
Zhijing Ye, Yunxuan Qin, Roland Harrison, et al.
International Journal of Molecular Sciences
|
January 12, 2017
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
Ruslan Cusnir, Cinzia Imberti, Robert C Hider, et al.
Dalton Transactions (Cambridge, England : 2003)
|
February 18, 2015
Deferitazole, a new orally active iron chelator
Robert C Hider, Xiaole Kong, Vincenzo Abbate, et al.
The British Journal of Surgery
|
July 6, 2010
Computed tomographic colonography in the diagnosis of colorectal cancer
M Sabanli, A Balasingam, W Bailey, et al.
Journal of Medicinal Chemistry
|
April 1, 2017
Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy
Sinan Battah, Robert C Hider, Alexander J MacRobert, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 1, 1995
Tryptic mapping of human chorionic gonadotropin by matrix-assisted laser desorption/ionization mass spectrometry
P Laidler, D A Cowan, R C Hider, et al.
British Journal of Haematology
|
June 6, 2003
Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry
Roland Fischer, Filomena Longo, Peter Nielsen, et al.
Journal of Medicinal Chemistry
|
February 21, 2012
Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake
Yongmin Ma, Sourav Roy, Xiaole Kong, et al.
Journal of Health Politics, Policy and Law
|
December 6, 2002
Compensation for medical injury in New Zealand: does "'no-fault" increase the level of claims making and reduce social and clinical selectivity?
Peter Davis, Roy Lay-Yee, Julie Fitzjohn, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
S L Hider, A Silman, D Bunn, et al.
Page
of 69